Publication | Open Access
Sunitinib‐induced macrocytosis in patients with metastatic renal cell carcinoma
45
Citations
7
References
2008
Year
Macrocytosis was a common occurrence after treatment with sunitinib but not sorafenib in patients with metastatic RCC. Sunitinib-induced macrocytosis is reversible with drug discontinuation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1